Methods for treating alcoholism

Details for Australian Patent Application No. 2005223655 (hide)

Owner Alkermes, Inc.

Inventors Mundel, Trevor; Ehrich, Elliot

Agent Pizzeys

Pub. Number AU-B-2005223655

PCT Pub. Number WO2005/089449

Priority 11/082,420 17.03.05 US; 60/554,658 19.03.04 US

Filing date 18 March 2005

Wipo publication date 29 September 2005

Acceptance publication date 18 October 2007

International Classifications

A61K 31/198 (2006.01)

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/515 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/089449 Priority application(s): WO2005/089449

5 October 2006 Assignment before Grant

  Alkermes Controlled Therapeutic, II. The application has been assigned to Alkermes, Inc. 2006

18 October 2007 Application Accepted

  Published as AU-B-2005223655

14 February 2008 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005223659-Benzamide and benzoate anti-HIV compounds

2005223654-Administration of cisplatin by inhalation